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Abstract
Background: Hydraulic dilatation is a novel method of cervical dilatation that is based on continuous controllable
dilatation (CCBD) by the pumping of fluid into the balloon extension of the system. The main advantage of this
procedure is that it allows control of and insight into the process of cervical dilatation.
Methods: For the purposes of our research, we created a new and upgraded system for CCBD which consists of a
programmed hydrostatic pump connected to a balloon extension. With regard to our aim to precisely measure and
determine the location of the cervical resistance, we placed two pressure-measuring films, one on the top and one
on the bottom of the balloon extension. This study included 42 patients in whom cervical resistance was measured
before suction curettage.
Results: Cervical dilatation and measurement of cervical resistance were successful in all patients. The analysis of
the pressure-measuring films showed that the points of highest resistance were located in the zone of the internal
cervical os and that these values were much higher than those in the zone of the external cervical os (0.402 versus
0.264 MPa at the upper pressure-sensitive film; 0.387 versus 0.243 MPa at the lower pressure-sensitive film). This
study also showed that an increase in cervical resistance in the zone of the internal cervical os was followed by an
increase in cervical resistance in the zone of the external cervical os.
Conclusions: During CCBD, the internal cervical os is the centre of cervical resistance, and the values do not decline
with the number of miscarriages or the number of previous births.
Trial registration number: ISRCTN Registry identifier: ISRCTN30949871. Date of registration: 13 May 2015.
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Background
Anatomically, the cervix is part of the uterus, but func-
tionally it is a unique organ. By definition, the cervix
represents both a barrier and a connection between the
internal female genital organs and the environment [1].
Cervical dilatation is a term that refers mostly to the
physiological dilatation that occurs during childbirth, al-
though artificial dilatation of the cervical canal is a com-
mon procedure in gynaecological practice that is used
for both therapeutic and diagnostic procedures, such as
hysteroscopy, explorative curettage or placement of
intrauterine contraceptive devices [2–4]. The most com-
mon method for cervical dilatation is to use Hegar dila-
tors. This method requires significant force, which may
lead to permanent damage of the cervical canal [5, 6].
Other methods of cervical dilatation involve the use of
osmotic dilators or prostaglandin analogues, which are
impractical, often nonfunctional and cause undesirable
effects such as cervical haemorrhage or uterine cramp-
ing [7–9].
Cervical dilatation by continuous controllable balloon
dilatation (CCBD) is a relatively new method that is
based on the continuous and controllable pumping of
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fluid into the balloon extension of the dilatation device
[10]. The main advantage of CCBD is that it gives the
physician control over the dilatation process and makes
the procedure safer for the patient and less stressful for
the physician than other methods. In recent studies,
CCBD proved to be more reliable and less invasive than
other methods and caused significantly less damage to the
cervical tissue compared with use of Hegar dilators [11].
CCBD is a safer and more reliable method of cervical dila-
tation than other methods and can also be used to moni-
tor and analyse the insufficiently researched process of
artificial dilatation of the uterine cervix. In our present
study, we sought to precisely determine the resistance
given by the uterine cervix during dilatation using the
CCBD method.
Methods
Study design
We conducted a prospective, controlled, clinical and ex-
perimental study at the Clinic of Gynaecology and Ob-
stetrics, Clinical Centre, Kragujevac, Serbia. The study
was approved by the ethics committee of the Clinical
Fig. 1 Upgraded system for continuous controllable balloon dilatation: Nexus 6000 hydrostatic pump (National Instruments, Austin, TX, USA) (1),
linear variable differential transformer displacement sensor (2), pressure sensor (3), dilatator device (4), driver for displacement sensor (5), enclosure
with USB-6008 data acquisition card (6), laptop computer (7) and RS232 to USB converter (8)
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Centre, Kragujevac, Serbia (approval number 01-4169).
The authors vouch for the completeness and accuracy of
the data and analyses. An independent data and safety
monitoring board monitored the study and reviewed the
protocol compliance and outcome data.
Study patients
This research study involved 42 patients who were hospi-
talised for termination of an unwanted pregnancy in the
fertility control ward of the Gynaecology and Obstetrics
Clinic in Kragujevac, Serbia, between May 2014 and May
2015. The inclusion criteria were age between 18 and
40 years, pregnancy verified by ultrasound, singleton preg-
nancy, gestational age of 10 weeks or less, absence of uter-
ine bleeding or cramping, cervix and uterus without
pathological changes and closed external cervical os
(ECO). If any of the inclusion criteria were not met, the
patient was not enrolled in the study. Before each experi-
ment was performed, the dimensions of the cervix (length,
anteroposterior and laterolateral diameters) and the loca-
tion of the ECO and internal cervical os (ICO) were deter-
mined by ultrasound. In addition, each patient’s medical
history with regard to previous births (by vaginal delivery)
and abortions was determined. The experiments were per-
formed with the understanding and appropriate informed
consent of each patient (Additional files 1 and 2).
Study methods
For the purpose of our research, we modified and upgraded
the system for CCBD [11]. In the upgraded CCBD system,
controllability over the process of dilatation is met on two
levels: control over the maximum diameter of dilatation
and control of the parameters of the dilatation process
(i.e., pressure in the balloon extension, dilatation speed).
These two levels of control are reached by using the Nexus
6000 hydrostatic pump (Chemyx, Stafford, TX, USA) and
our original software application that allows the dilatation
process to operate under strictly controlled conditions
(dilatation process lasted 100 seconds; pressure in the bal-
loon extension did not exceed 2 MPa). The tracking and
measurement of the dilatation parameters were performed
by the pressure sensor, which is located on the dilatator de-
vice, as well as by the displacement sensor, which is at-
tached to the hydrostatic pump, as shown in Fig. 1.
In our aim to precisely measure and basically map the
resistance along the cervical canal during CCBD, we used
the following pressure-sensitive films (PSFs): FUJIFILM
Ultra Super Low Pressure (Fujifilm, Tokyo, Japan). Under
the influence of external force on the PSF, microcapsules
in component A of the film rupture and the released red
paint is absorbed by the special material in component B,
as shown in Fig. 2a. The width of the PSF used in our
study was 3 mm and the length was 70 mm. Adhesive tape
Fig. 2 Pressure-sensitive film. a Scheme of the pressure sensitive film; b Modified pressure sensitive film before dilatation
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was placed at both ends of the PSF to keep components A
and B together during the experiment. We also placed ad-
hesive tape at the top ends of the PSF to avoid their move-
ment during placement of the balloon extension in the
cervical canal, as shown in Fig. 2b. Owing to the presence
of cervical mucus and blood during the experiment, we
had to isolate our PSF with transparent plastic foil. Finally,
in every experiment, we used two PSFs, which were placed
on the top and the bottom, respectively, of the balloon ex-
tension of the CCBD system.
After completion of dilatation, the PSFs were collected,
scanned and converted into their respective digital forms,
which were further analysed using the MATLAB program
(MathWorks, Natick, MA, USA). The final versions of the
processed PSFs are displayed in the Results section.
Statistical analysis
All of the statistical analyses were performed with IBM
SPSS 22.0 for Windows software (IBM, Armonk, NY,
USA). All data were numeric. A normal distribution of con-
tinuous data was tested using the Kolmogorov–Smirnov
test. The correlation between the observed parameters was
analysed using Pearson’s (parametric data) and Spearman’s
(nonparametric data) correlation coefficients. All of the
data in this study are expressed as the mean ± standard
error. p < 0.05 was considered significant.
Results
The values of the cervical resistance during CCBD on the
upper PSF, which were measured in the zone of the ICO,
ranged from 0.144 MPa to 0.559 МРа, with an average of
0.402 ± 0.097 МРа. As for the ECO, the values of the cer-
vical resistance during CCBD on the upper film ranged
from 0.043 MPa to 0.467 MPa, with an average of 0.264 ±
0.108 MPa. Further analysis showed that the values of cer-
vical resistance in the zone of the ICO were in positive
statistical correlation with the values of the cervical resist-
ance measured in the zone of the ECO (p = 0.000). How-
ever, no statistically significant correlation was found
between the cervical resistance measured in the zone of
the ICO and the number of previous births or the number
of previous miscarriages, as presented in Tables 1 and 2.
The values for cervical resistance during CCBD on the
lower PSF were measured in the zone of the ICO and
ranged from 0.135 МРа to 0.582 МРа, with an average of
0.387 ± 0.089 МРа. As for the ECO, the values for cervical
resistance on the lower PSF ranged from 0.047 МРа to
0.518 МРа, with an average of 0.243 ± 0.120 МРа. Similar
Table 3 Correlation of the cervical resistance values measured
in the zone of the ICO on the lower pressure-sensitive film and
other parameters
Lower film ICO p Value
Number of births ρ = −0.109a 0.497
Number of miscarriages ρ = −0.083a 0.604
Number of abortions ρ = 0.007a 0.966
Lower film ECO r = 0.455b 0.003c
Upper film ICO r = 0.169b 0.290
Upper film ECO r = 0.207b 0.194
ICO internal cervical os, ECO external cervical os
aSpearman’s correlation coefficient
bPearson’s correlation coefficient
cStatistically significant correlation
Table 4 Correlation of the cervical resistance values measured
in the zone of ECO on the lower pressure-sensitive film and
other parameters
Lower film ECO p Value
Number of births ρ = −0.054a 0.738
Number of miscarriages ρ = 0.035a 0.829
Number of abortions ρ = −0.118a 0.462
Lower film ICO r = 0.455b 0.003c
Upper film ICO r = 0.255b 0.107
Upper film ECO r = 0.657b 0.000c
ICO internal cervical os, ECO external cervical os
aSpearman’s correlation coefficient
bPearson’s correlation coefficient
cStatistically significant correlation
Table 2 Correlation of the cervical resistance values measured
in the zone of ECO on the upper pressure-sensitive film and
other parameters
Upper film ECO p Value
Number of births ρ = 0.009a 0.956
Number of miscarriages ρ = 0.042a 0.796
Number of abortions ρ = 0.034a 0.831
Upper film ICO r = 0.611b 0.000c
Lower film ICO r = 0.207b 0.194
Lower film ECO r = 0.657b 0.000c
ICO internal cervical os, ECO external cervical os
aSpearman’s correlation coefficient
bPearson’s correlation coefficient
cStatistically significant correlation
Table 1 Correlation of cervical resistance measured in the
zone of the ICO on the upper pressure-sensitive film and other
parameters
Upper film ICO p Value
Number of births ρ = −0.022a 0.891
Number of miscarriages ρ = 0.025a 0.878
Number of abortions ρ = 0.024a 0.881
Upper film ECO r = 0.611b 0.000c
Lower film ICO r = 0.169b 0.290
Lower film ECO r = 0.255b 0.107
ICO internal cervical os, ECO external cervical os
aSpearman’s correlation coefficient
bPearson’s correlation coefficient
cStatistically significant correlation
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to the upper PSF, a positive statistical correlation was
found between the values of cervical resistance measured
in the zones of the ICO and ECO (p = 0.003), whereas no
statistically significant correlation was found for the other
parameters that were investigated in this study, as shown
in Tables 3 and 4.
Processed PSFs gave us insight into the map of cervical
resistance during dilatation with the CCBD system. As
shown in Figs. 3 and 4, the zones of the highest resist-
ance are matched with the anatomic sites of the ICO
and ECO of the cervix, predicted by cervical dimensions
acquired by ultrasound, before the intervention.
Discussion
The use of the CCBD system allowed us to investigate, for
the first time to our knowledge, the phenomenon of cer-
vical dilatation during the process itself. Previous research
on the mechanical properties of cervical tissue is scarce,
and the research that has been conducted is mostly lim-
ited to studies in ex vivo conditions. One of the first
Fig. 3 Pressure-sensitive films (PSFs) of patient 3 with cervical diameters and marked zones of internal and external cervical os: cervical length
54 mm, anteroposterior diameter 26 mm and laterolateral diameter 27 mm. a Upper PSF b Lower PSF
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studies on the mechanical properties of the human cervix
was conducted by Conrad et al., who used human cervical
tissue samples that were obtained after hysterectomy.
Their research showed that tissue samples from the ICO
exhibited the greatest resistance to the uniaxial tension
[12, 13]. Later, Petersen et al. conducted research on cer-
vical tissue samples of nonpregnant women. They showed
that the biomechanical strength of the uterine cervix is
passive and that it is derived from the high concentration
of collagen fibres in the cervical stroma [14–16]. One of
the rare in vivo studies on the mechanical characteristics
of cervical tissue was conducted by Mazza et al. Eight ex-
periments were performed in vivo, and four were per-
formed ex vivo. The results showed that the ex vivo
mechanical response of the cervical tissue did not differ
considerably from that observed in vivo [17, 18].
The research study most similar to ours was con-
ducted by Kiwi et al. They used the specially designed
balloon extensions to dilate the cervix and showed that
the elastic properties of the cervix decline as the number
Fig. 4 Pressure-sensitive films (PSFs) of patient 36 with cervical diameters and marked zones of internal and external cervical os: cervical length
50 mm, anteroposterior diameter 28 mm and laterolateral diameter 30 mm. a Upper PSF b Lower PSF
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of previous miscarriages increases [19, 20]. The same
conclusion was reached by Anthony et al., who mea-
sured the cervical resistance index in nonpregnant
women before some of the routine gynaecological inter-
ventions were performed. The results of their study
showed that women with a history of one or more mis-
carriages have much lower values of cervical resistance
than those without previous miscarriages [21, 22].
The main aim of our research was to precisely meas-
ure, analyse and create a map along the cervical canal
during the dilatation of the uterine cervix. With the use
of the CCBD system and the application of the PSFs,
we managed to locate every point of resistance along
the upper and lower sides of the cervical canal. An ana-
lysis of the PSFs showed that the points of greatest re-
sistance are in the zone of the ICO and that these
values are much higher than those in the zone of the
ECO for both PSFs. The reason for this finding derives
from the difference between the two cervical ossa. With
the exception of densely packed collagen fibres, the
ICO contains a high concentration of arranged muscle
fibres. However, a statistically positive correlation exists
between the values of cervical resistance measured in
the zones of the ICO and ECO for both of the PSFs.
That means that despite the fact that the ICO is the
centre of cervical resistance during CCBD, the dilata-
tion occurs only after simultaneous loosening of both
cervical ossa. These findings are in accordance with
those of other studies of the mechanical properties of
the uterine cervix. On the contrary, however, in our
study, no statistically significant correlation was found
between values of cervical resistance and the number of
previous miscarriages. This result is opposite to that of
previous studies. The reason for this contradiction
might lie in the fact that both the cervical resistance
index and the elastic properties of the cervix were pre-
viously investigated in nonpregnant women, whereas
our study on cervical resistance was performed in
women before the termination of unwanted pregnan-
cies, before 10 weeks of gestation.
Conclusions
During CCBD, the ICO is the centre of cervical resist-
ance, and the values of the measured resistance are in
positive correlation with the resistance measured in
the zone of the ECO. There is no significant correl-
ation between cervical resistance during dilatation with
CCBD system and number of previous births or mis-
carriages. Future investigation of cervical resistance
and response to CCBD requires a collaborative effort
between engineers and clinicians and will provide fur-
ther insight into the biomechanical aspects of the cer-
vical tissue.
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